Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Rodríguez-Martínez JM[au]:

Quinolone Resistance Reversion by Targeting the SOS Response. Recacha E et al. mBio. (2017)

Plasmid-mediated quinolone resistance: Two decades on. Rodríguez-Martínez JM et al. Drug Resist Updat. (2016)

Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries. Yanat B et al. Eur J Clin Microbiol Infect Dis. (2017)

Search results

Items: 1 to 50 of 81

1.

A prospective, multicenter case control study of risk factors for acquisition and mortality in Enterobacter species bacteremia.

Álvarez-Marín R, Navarro-Amuedo D, Gasch-Blasi O, Rodríguez-Martínez JM, Calvo-Montes J, Lara-Contreras R, Lepe-Jiménez JA, Tubau-Quintano F, Cano-García ME, Rodríguez-López F, Rodríguez-Baño J, Pujol-Rojo M, Torre-Cisneros J, Martínez-Martínez L, Pascual-Hernández Á, Jiménez-Mejías ME; Spanish Network for Research in Infectious Diseases/Enterobacter spp. Bacteriemia Project group.

J Infect. 2019 Oct 1. pii: S0163-4453(19)30288-9. doi: 10.1016/j.jinf.2019.09.017. [Epub ahead of print]

PMID:
31585192
2.

Association of blaOXA-1, and aac(6')-Ib-cr with ST405 K. pneumoniae clone.

Luque-González P, López-Cerero L, Díaz-de-Alba P, Rodríguez-Martínez JM.

Enferm Infecc Microbiol Clin. 2019 Jun - Jul;37(6):417-418. doi: 10.1016/j.eimc.2018.06.001. Epub 2018 Jul 4. English, Spanish. No abstract available.

PMID:
31155040
3.

Suppression of the SOS response modifies spatiotemporal evolution, post-antibiotic effect, bacterial fitness and biofilm formation in quinolone-resistant Escherichia coli.

Recacha E, Machuca J, Díaz-Díaz S, García-Duque A, Ramos-Guelfo M, Docobo-Pérez F, Blázquez J, Pascual A, Rodríguez-Martínez JM.

J Antimicrob Chemother. 2019 Jan 1;74(1):66-73. doi: 10.1093/jac/dky407.

PMID:
30329046
4.

Prevalence of ST131 Clone Producing Both ESBL CTX-M-15 and AAC(6')Ib-cr Among Ciprofloxacin-Resistant Escherichia coli Isolates from Yemen.

Alsharapy SA, Yanat B, Lopez-Cerero L, Nasher SS, Díaz-De-Alba P, Pascual Á, Rodríguez-Martínez JM, Touati A.

Microb Drug Resist. 2018 Jun 8. doi: 10.1089/mdr.2018.0024. [Epub ahead of print]

PMID:
29883247
5.

Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake.

Martín-Gutiérrez G, Docobo-Pérez F, Rodriguez-Beltrán J, Rodríguez-Martínez JM, Aznar J, Pascual A, Blázquez J.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01899-17. doi: 10.1128/AAC.01899-17. Print 2018 Jan.

6.

Quinolone Resistance Reversion by Targeting the SOS Response.

Recacha E, Machuca J, Díaz de Alba P, Ramos-Güelfo M, Docobo-Pérez F, Rodriguez-Beltrán J, Blázquez J, Pascual A, Rodríguez-Martínez JM.

mBio. 2017 Oct 10;8(5). pii: e00971-17. doi: 10.1128/mBio.00971-17.

7.

Cellular Response to Ciprofloxacin in Low-Level Quinolone-Resistant Escherichia coli.

Machuca J, Recacha E, Briales A, Díaz-de-Alba P, Blazquez J, Pascual Á, Rodríguez-Martínez JM.

Front Microbiol. 2017 Jul 19;8:1370. doi: 10.3389/fmicb.2017.01370. eCollection 2017.

8.

Molecular topology: A new strategy for antimicrobial resistance control.

Zanni R, Galvez-Llompart M, Machuca J, Garcia-Domenech R, Recacha E, Pascual A, Rodriguez-Martinez JM, Galvez J.

Eur J Med Chem. 2017 Sep 8;137:233-246. doi: 10.1016/j.ejmech.2017.05.055. Epub 2017 May 30.

PMID:
28595068
9.

Molecular Characterization of Fluoroquinolone-Resistant Haemophilus parainfluenzae Clinical Isolates in Spain.

López-Hernández I, Machuca J, Díaz de Alba P, Sarvisé C, Gómez F, Rodríguez-Martínez JM, Pascual A.

Microb Drug Resist. 2017 Dec;23(8):935-939. doi: 10.1089/mdr.2016.0186. Epub 2017 Apr 17.

PMID:
28414572
10.

Cytotoxic Effect Associated with Overexpression of QNR Proteins in Escherichia coli.

Machuca J, Diaz de Alba P, Recacha E, Pascual Á, Rodriguez-Martinez JM.

Microb Drug Resist. 2017 Oct;23(7):822-825. doi: 10.1089/mdr.2016.0245. Epub 2017 Mar 13.

PMID:
28287903
11.

Plasmidic qnr Genes Confer Clinical Resistance to Ciprofloxacin under Urinary Tract Physiological Conditions.

Martín-Gutiérrez G, Rodríguez-Martínez JM, Pascual Á, Rodríguez-Beltrán J, Blázquez J.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02615-16. doi: 10.1128/AAC.02615-16. Print 2017 Apr.

12.

Molecular insights into fosfomycin resistance in Escherichia coli.

Ballestero-Téllez M, Docobo-Pérez F, Portillo-Calderón I, Rodríguez-Martínez JM, Racero L, Ramos-Guelfo MS, Blázquez J, Rodríguez-Baño J, Pascual A.

J Antimicrob Chemother. 2017 May 1;72(5):1303-1309. doi: 10.1093/jac/dkw573.

PMID:
28093485
13.

Rapid detection of the plasmid-mediated quinolone resistance determinant AAC(6')-Ib-cr in Enterobacteriaceae by MALDI-TOF MS analysis.

Oviaño M, Rodríguez-Martínez JM, Pascual Á, Bou G.

J Antimicrob Chemother. 2017 Apr 1;72(4):1074-1080. doi: 10.1093/jac/dkw552.

PMID:
28065892
14.

Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae.

Ballestero-Téllez M, Docobo-Pérez F, Rodríguez-Martínez JM, Conejo MC, Ramos-Guelfo MS, Blázquez J, Rodríguez-Baño J, Pascual A.

Clin Microbiol Infect. 2017 May;23(5):325-331. doi: 10.1016/j.cmi.2016.12.022. Epub 2017 Jan 3.

15.

Plasmid-mediated quinolone resistance: Two decades on.

Rodríguez-Martínez JM, Machuca J, Cano ME, Calvo J, Martínez-Martínez L, Pascual A.

Drug Resist Updat. 2016 Nov;29:13-29. doi: 10.1016/j.drup.2016.09.001. Epub 2016 Sep 13. Review.

PMID:
27912841
16.

Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries.

Yanat B, Rodríguez-Martínez JM, Touati A.

Eur J Clin Microbiol Infect Dis. 2017 Mar;36(3):421-435. doi: 10.1007/s10096-016-2847-x. Epub 2016 Nov 26. Review.

PMID:
27889879
17.

First report of the plasmid-mediated colistin resistance gene mcr-1 in a clinical Escherichia coli isolate in Algeria.

Yanat B, Machuca J, Yahia RD, Touati A, Pascual Á, Rodríguez-Martínez JM.

Int J Antimicrob Agents. 2016 Dec;48(6):760-761. doi: 10.1016/j.ijantimicag.2016.09.003. Epub 2016 Sep 30. No abstract available.

PMID:
27742204
18.

Occurrence of the Plasmid-Mediated Fluoroquinolone Resistance qepA1 Gene in Two Clonal Clinical Isolates of CTX-M-15-Producing Escherichia coli from Algeria.

Yanat B, Dali Yahia R, Yazi L, Machuca J, Díaz-De-Alba P, Touati A, Pascual Á, Rodríguez-Martínez JM.

Microb Drug Resist. 2017 Jun;23(4):497-499. doi: 10.1089/mdr.2016.0135. Epub 2016 Oct 13.

PMID:
27736309
19.

Impact of AAC(6')-Ib-cr in combination with chromosomal-mediated mechanisms on clinical quinolone resistance in Escherichia coli.

Machuca J, Ortiz M, Recacha E, Díaz-De-Alba P, Docobo-Perez F, Rodríguez-Martínez JM, Pascual Á.

J Antimicrob Chemother. 2016 Nov;71(11):3066-3071. Epub 2016 Jul 11.

PMID:
27494906
20.

Urinary Tract Physiological Conditions Promote Ciprofloxacin Resistance in Low-Level-Quinolone-Resistant Escherichia coli.

Martín-Gutiérrez G, Rodríguez-Beltrán J, Rodríguez-Martínez JM, Costas C, Aznar J, Pascual Á, Blázquez J.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4252-8. doi: 10.1128/AAC.00602-16. Print 2016 Jul.

21.

Characterization of Plasmid-Mediated Quinolone Resistance Determinants in High-Level Quinolone-Resistant Enterobacteriaceae Isolates from the Community: First Report of qnrD Gene in Algeria.

Yanat B, Machuca J, Díaz-De-Alba P, Mezhoud H, Touati A, Pascual Á, Rodríguez-Martínez JM.

Microb Drug Resist. 2017 Jan;23(1):90-97. doi: 10.1089/mdr.2016.0031. Epub 2016 Apr 26.

PMID:
27115732
22.

Assessment of Chromosomal DNA Fragmentation by Quinolones in an Isogenic Collection of Escherichia coli with Defined Resistance Mechanisms.

Rodríguez-Martínez JM, Santiso R, Machuca J, Bou G, Pascual Á, Fernández JL.

Microb Drug Resist. 2016 Jul;22(5):354-9. doi: 10.1089/mdr.2015.0298. Epub 2016 Feb 18.

PMID:
26890225
23.

Assessment of a phenotypic algorithm to detect plasmid-mediated quinolone resistance in Enterobacteriaceae.

Rodríguez-Martínez JM, López-Cerero L, Díaz-de-Alba P, Chamizo-López FJ, Polo-Padillo J, Pascual Á.

J Antimicrob Chemother. 2016 Mar;71(3):845-7. doi: 10.1093/jac/dkv392. Epub 2015 Nov 26. No abstract available.

PMID:
26612871
24.

Reduced Susceptibility to Cefepime in Clinical Isolates of Enterobacteriaceae Producing OXA-1 Beta-Lactamase.

Torres E, López-Cerero L, Rodríguez-Martínez JM, Pascual Á.

Microb Drug Resist. 2016 Mar;22(2):141-6. doi: 10.1089/mdr.2015.0122. Epub 2015 Aug 21.

PMID:
26295796
25.

Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance.

Docobo-Pérez F, Drusano GL, Johnson A, Goodwin J, Whalley S, Ramos-Martín V, Ballestero-Tellez M, Rodriguez-Martinez JM, Conejo MC, van Guilder M, Rodríguez-Baño J, Pascual A, Hope WW.

Antimicrob Agents Chemother. 2015 Sep;59(9):5602-10. doi: 10.1128/AAC.00752-15. Epub 2015 Jun 29.

26.

Effect of the efflux pump QepA2 combined with chromosomally mediated mechanisms on quinolone resistance and bacterial fitness in Escherichia coli.

Machuca J, Briales A, Díaz-de-Alba P, Martínez-Martínez L, Pascual Á, Rodríguez-Martínez JM.

J Antimicrob Chemother. 2015 Sep;70(9):2524-7. doi: 10.1093/jac/dkv144. Epub 2015 Jun 3.

PMID:
26041043
27.

Comparison of clinical categories for Escherichia coli harboring specific qnr and chromosomal-mediated fluoroquinolone resistance determinants according to CLSI and EUCAST.

Machuca J, Briales A, Díaz-de-Alba P, Martínez-Martínez L, Rodríguez-Martínez JM, Pascual Á.

Enferm Infecc Microbiol Clin. 2016 Mar;34(3):188-90. doi: 10.1016/j.eimc.2015.01.019. Epub 2015 Mar 12.

PMID:
25772329
28.

Challenges to accurate susceptibility testing and interpretation of quinolone resistance in Enterobacteriaceae: results of a Spanish multicentre study.

Rodriguez-Martinez JM, Machuca J, Calvo J, Diaz-de-Alba P, Rodríguez-Mirones C, Gimeno C, Martinez-Martinez L, Pascual Á.

J Antimicrob Chemother. 2015 Jul;70(7):2038-47. doi: 10.1093/jac/dkv059. Epub 2015 Mar 4.

PMID:
25745103
29.

Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli.

Machuca J, Briales A, Labrador G, Díaz-de-Alba P, López-Rojas R, Docobo-Pérez F, Martínez-Martínez L, Rodríguez-Baño J, Pachón ME, Pascual A, Rodríguez-Martínez JM.

J Antimicrob Chemother. 2014 Dec;69(12):3203-15. doi: 10.1093/jac/dku308. Epub 2014 Aug 19.

PMID:
25139837
30.

Lactococcus garvieae carries a chromosomally encoded pentapeptide repeat protein that confers reduced susceptibility to quinolones in Escherichia coli producing a cytotoxic effect.

Gibello A, Díaz de Alba P, Blanco MM, Machuca J, Cutuli MT, Rodríguez-Martínez JM.

Res Microbiol. 2014 Sep;165(7):590-9. doi: 10.1016/j.resmic.2014.05.033. Epub 2014 Jun 3.

PMID:
24965125
31.

Presence of quinolone resistance to qnrB1 genes and blaOXA-48 carbapenemase in clinical isolates of Klebsiella pneumoniae in Spain.

Rodríguez Martínez JM, Díaz-de Alba P, Lopez-Cerero, Ruiz-Carrascoso G, Gomez-Gil R, Pascual A.

Enferm Infecc Microbiol Clin. 2014 Aug-Sep;32(7):441-2. doi: 10.1016/j.eimc.2014.02.013. Epub 2014 Apr 18.

PMID:
24746402
32.

[High level of fluoroquinolone resistance in a respiratory isolate of Haemophilus parainfluenzae associated with a new mutation in ParC].

López-Hernández I, Rodríguez-Martínez JM, Ortiz-de la Tabla V, Pascual A.

Enferm Infecc Microbiol Clin. 2013 Nov;31(9):636-7. doi: 10.1016/j.eimc.2013.03.013. Epub 2013 Apr 25. Spanish. No abstract available.

PMID:
23623581
33.

Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83Leu.

Domínguez-Herrera J, Velasco C, Docobo-Pérez F, Rodríguez-Martínez JM, López-Rojas R, Briales A, Pichardo C, Díaz-de-Alba P, Rodríguez-Baño J, Pascual A, Pachón J.

J Antimicrob Chemother. 2013 Jul;68(7):1609-15. doi: 10.1093/jac/dkt063. Epub 2013 Mar 14.

PMID:
23493313
34.

Contribution of OqxAB efflux pumps to quinolone resistance in extended-spectrum-β-lactamase-producing Klebsiella pneumoniae.

Rodríguez-Martínez JM, Díaz de Alba P, Briales A, Machuca J, Lossa M, Fernández-Cuenca F, Rodríguez Baño J, Martínez-Martínez L, Pascual Á.

J Antimicrob Chemother. 2013 Jan;68(1):68-73. doi: 10.1093/jac/dks377. Epub 2012 Sep 25.

PMID:
23011289
35.

Exposure to diverse antimicrobials induces the expression of qnrB1, qnrD and smaqnr genes by SOS-dependent regulation.

Briales A, Rodriguez-Martinez JM, Velasco C, Machuca J, Díaz de Alba P, Blazquez J, Pascual A.

J Antimicrob Chemother. 2012 Dec;67(12):2854-9. doi: 10.1093/jac/dks326. Epub 2012 Aug 22.

PMID:
22915457
36.

Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain.

Briales A, Rodríguez-Martínez JM, Velasco C, de Alba PD, Rodríguez-Baño J, Martínez-Martínez L, Pascual A.

Int J Antimicrob Agents. 2012 May;39(5):431-4. doi: 10.1016/j.ijantimicag.2011.12.009. Epub 2012 Feb 22.

PMID:
22365240
37.

[Combination of bla(VIM-1) and qnrS2 on the same plasmid in Klebsiella oxytoca and Klebsiella pneumoniae isolates in Seville].

Rodríguez-Martínez JM, Conejo MC, Díaz de Alba P, López-Cerero L, Fernandez-Echauri P, Pascual A.

Enferm Infecc Microbiol Clin. 2012 May;30(5):246-8. doi: 10.1016/j.eimc.2011.09.020. Epub 2012 Jan 16. Spanish.

PMID:
22257559
38.

Group IIC intron with an unusual target of integration in Enterobacter cloacae.

Rodríguez-Martínez JM, Nordmann P, Poirel L.

J Bacteriol. 2012 Jan;194(1):150-60. doi: 10.1128/JB.05786-11. Epub 2011 Oct 21.

39.

Genetic characterization of an extended-spectrum AmpC cephalosporinase with hydrolysing activity against fourth-generation cephalosporins in a clinical isolate of Enterobacter aerogenes selected in vivo.

Rodríguez-Martínez JM, Fernández-Echauri P, Fernández-Cuenca F, Diaz de Alba P, Briales A, Pascual A.

J Antimicrob Chemother. 2012 Jan;67(1):64-8. doi: 10.1093/jac/dkr423. Epub 2011 Oct 16.

PMID:
22001269
40.

[Absence of efflux pump plasmid-mediated quinolone resistance QacBIII in bacteremic isolates of Staphylococcus aureus in the Virgen Macarena hospital area in Seville].

Infante-Martínez V, Rodríguez-Martínez JM, Velasco C, Pascual A.

Enferm Infecc Microbiol Clin. 2012 Jan;30(1):51. doi: 10.1016/j.eimc.2011.07.019. Epub 2011 Oct 11. Spanish. No abstract available.

PMID:
21996425
41.

Production of a plasmid-encoded OXA-72 β-lactamase associated with resistance to carbapenems in a clinical isolate Acinetobacter junii.

Fernández-Cuenca F, Rodríguez-Martínez JM, Gómez-Sánchez MA, de Alba PD, Infante-Martínez V, Pascual A.

Int J Antimicrob Agents. 2012 Jan;39(1):93-4. doi: 10.1016/j.ijantimicag.2011.07.017. Epub 2011 Oct 7. No abstract available.

PMID:
21982835
42.

Evaluation of three automated systems for susceptibility testing of enterobacteria containing qnrB, qnrS, and/or aac(6')-Ib-cr.

Calvo J, Cano ME, Pitart C, Marco F, Rodríguez-Martínez JM, Pascual A, Martínez-Martínez L.

J Clin Microbiol. 2011 Sep;49(9):3343-5. doi: 10.1128/JCM.00563-11. Epub 2011 Jul 20.

43.

Discrepancies in fluoroquinolone clinical categories between the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI for Escherichia coli harbouring qnr genes and mutations in gyrA and parC.

Rodríguez-Martínez JM, Briales A, Velasco C, Díaz de Alba P, Martínez-Martínez L, Pascual A.

J Antimicrob Chemother. 2011 Jun;66(6):1405-7. doi: 10.1093/jac/dkr117. Epub 2011 Mar 21. No abstract available.

PMID:
21427105
44.

In vitro effect of qnrA1, qnrB1, and qnrS1 genes on fluoroquinolone activity against isogenic Escherichia coli isolates with mutations in gyrA and parC.

Briales A, Rodríguez-Martínez JM, Velasco C, Díaz de Alba P, Domínguez-Herrera J, Pachón J, Pascual A.

Antimicrob Agents Chemother. 2011 Mar;55(3):1266-9. doi: 10.1128/AAC.00927-10. Epub 2010 Dec 20.

45.

Molecular characterization of high-level fluoroquinolone resistance in a clinical isolate of Haemophilus parainfluenzae.

Rodríguez-Martínez JM, López-Hernández I, Pascual A.

J Antimicrob Chemother. 2011 Mar;66(3):673-5. doi: 10.1093/jac/dkq473. Epub 2010 Dec 1. No abstract available.

PMID:
21127039
46.

Plasmid-mediated quinolone resistance: an update.

Rodríguez-Martínez JM, Cano ME, Velasco C, Martínez-Martínez L, Pascual A.

J Infect Chemother. 2011 Apr;17(2):149-82. doi: 10.1007/s10156-010-0120-2. Epub 2010 Oct 1. Review.

PMID:
20886256
47.

Genetic and functional variability of AmpC-type β-lactamases from Acinetobacter baumannii.

Rodríguez-Martínez JM, Poirel L, Nordmann P.

Antimicrob Agents Chemother. 2010 Nov;54(11):4930-3. doi: 10.1128/AAC.00427-10. Epub 2010 Aug 16.

48.

Extended-spectrum cephalosporinase in Acinetobacter baumannii.

Rodríguez-Martínez JM, Nordmann P, Ronco E, Poirel L.

Antimicrob Agents Chemother. 2010 Aug;54(8):3484-8. doi: 10.1128/AAC.00050-10. Epub 2010 Jun 14.

49.

Characterization of DIM-1, an integron-encoded metallo-beta-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands.

Poirel L, Rodríguez-Martínez JM, Al Naiemi N, Debets-Ossenkopp YJ, Nordmann P.

Antimicrob Agents Chemother. 2010 Jun;54(6):2420-4. doi: 10.1128/AAC.01456-09. Epub 2010 Mar 22.

50.

Characterization of fluoroquinolone resistance in a clinical isolate of Pseudomonas stutzeri.

Rodríguez-Martínez JM, Poirel L, Al Naiemi N, Debets-Ossenkopp YJ, Nordmann P.

J Antimicrob Chemother. 2010 Feb;65(2):366-7. doi: 10.1093/jac/dkp441. Epub 2009 Dec 14. No abstract available.

PMID:
20008448

Supplemental Content

Loading ...
Support Center